Articles related to VITAMINS/SUPPLEMENTS

A manufacturer-funded randomized trial involving 61 participants reported improved vascular function markers and lower systolic blood pressure with a multi-ingredient supplement over six months. Cardiovascular event reduction and long-term safety were not established.

A review identified 15 reports of Wernicke encephalopathy among patients receiving GLP-1 therapies, most accompanied by poor intake, vomiting, weight loss, or malnutrition, highlighting a rare safety signal without establishing drug-related causality.

Five years after participation in randomized trials, children with fetal alcohol spectrum disorder who received choline supplementation during early childhood demonstrated higher nonverbal IQ and working-memory performance than peers who received placebo, suggesting the intervention may influence long-term neurodevelopmental trajectories.

Nearly one in six pediatric GLP-1 receptor agonist users received a nutritional-deficiency or related diagnosis within one year, while nutrition counseling remained limited and generally occurred months after treatment initiation.

Experts reviewing available evidence suggest melatonin and magnesium may support sleep through different mechanisms, though benefits appear dependent on the underlying cause of sleep disturbance and overall evidence remains mixed, particularly for magnesium.

Targeted vitamin D supplementation successfully addressed widespread vitamin D insufficiency among post-myocardial infarction patients but did not significantly reduce major adverse cardiovascular events during more than four years of follow-up.